| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/23/2009 | WO2009153662A1 New uses of lactic acid bacteria and bifidobacteria |
| 12/23/2009 | WO2009153554A1 Thieno-pyridine derivatives as mek inhibitors |
| 12/23/2009 | WO2009153182A1 Novel heteroaryl carboxamide derivatives |
| 12/23/2009 | WO2009133470A3 Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level |
| 12/23/2009 | WO2009133310A3 Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 12/23/2009 | WO2009129408A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 12/23/2009 | WO2009074969A3 Spingosine-1-phosphate, analogues and antagonists for use as medicaments |
| 12/23/2009 | EP2135613A1 Remedy and diagnostic for mitochondrial dysfunction brain disease |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |
| 12/23/2009 | EP2135605A2 Therapeutic delivery of carbon monoxide |
| 12/23/2009 | EP2134720A1 Heterocyclic spiro-compounds |
| 12/23/2009 | EP2134703A1 Amide derivatives as calcium channel blockers |
| 12/23/2009 | EP2134344A1 Reduction of adverse events.after percutaneous intervention by use of a thrombin receptor antagonist |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
| 12/23/2009 | EP1483297B1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1356816B1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/23/2009 | EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 12/23/2009 | EP1164874B1 Use of negatively charged, non-digestible polysaccharide hydrolysates for reducing transport through tight junctions of the intestin |
| 12/23/2009 | CN101611028A Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 12/23/2009 | CN101611023A 1-phenyl 1-thio-d-glucitol derivative |
| 12/23/2009 | CN101611012A Cycloalkylamine substituted isoquinoline derivatives |
| 12/23/2009 | CN101610779A 5ht4受体拮抗药 5ht4 receptor antagonist |
| 12/23/2009 | CN101610777A Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 12/23/2009 | CN101610771A Therapeutic agent for liver cancer |
| 12/23/2009 | CN101610767A Combination therapy of substituted oxazolidinones |
| 12/23/2009 | CN101610765A New combination for use in the treatment of inflammatory disorders |
| 12/23/2009 | CN101610688A Polyphenol extraction process |
| 12/23/2009 | CN101607979A Pentacylic triterpanes-vitamin C conjugates as well as preparation method and medical application thereof |
| 12/23/2009 | CN101607958A Quinazoline compounds |
| 12/23/2009 | CN101607954A Danshensu derivative, preparation method thereof, and application thereof in pharmacy |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN101607907A Substituted benzoic acid derivative and synthesizing method thereof and application thereof |
| 12/23/2009 | CN101607904A Danshensu derivatives and synthesis method and application thereof |
| 12/23/2009 | CN101607897A (Z)-2-acetyloxy-3-(3,4-dihydroxylbenzenyl) acrylic acid and synthesis method and application thereof |
| 12/23/2009 | CN101607070A Pharmaceutical composition for treating heart cerebrovascular disease |
| 12/23/2009 | CN101607069A Chinese traditional medicine for treating phlebitis, old lower extremity venous ulcer and venous purpura disease |
| 12/23/2009 | CN101607049A Separation and concentration method of drug extract liquid for preparing hemorrhoid diminishing preparation |
| 12/23/2009 | CN101607048A Application of herba lophatheri flavonoid for preparing medication for treating hypotension |
| 12/23/2009 | CN101607025A Drug for curing and preventing cardiorenal failure and preparation method thereof |
| 12/23/2009 | CN101607007A Traditional Chinese medicine preparation for treating cerebral circulation insufficiency |
| 12/23/2009 | CN101607006A Application of Chinese medicinal composition in preparing medicament for treating hypertension |
| 12/23/2009 | CN101607000A Seven-ingredient Tong-mai hot compress paste as well as prevention and treatment thereof for infusion phlebitis |
| 12/23/2009 | CN101606999A Traditional Chinese medicine preparation for treating type diabetes B lower limb atherosclerosis |
| 12/23/2009 | CN101606976A Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology |
| 12/23/2009 | CN101606956A Application of extract of ginkgo biloba leaves in preparing medicaments for resisting arrhythmia |
| 12/23/2009 | CN101606944A Application of vitexin rhamnoside in vasodilative medicine preparation |
| 12/23/2009 | CN101606929A Application of deoxypodophyllotoxin |
| 12/23/2009 | CN101606926A Medicinal composition containing dopexamine hydrochloride |
| 12/23/2009 | CN101606916A Pharmaceutical formulations of modafinil |
| 12/23/2009 | CN101606915A Novel pharmaceutical formulations of modafinil |
| 12/23/2009 | CN101606740A Method for preparing sugarless mulberry leaf beverage and application thereof |
| 12/23/2009 | CN101606703A Nutritional food with function of lowering blood pressure and preparation method thereof |
| 12/23/2009 | CN101606693A Natural colour lipid-lowering and weight-losing porridge and preparation method |
| 12/23/2009 | CN100572527C Medium for culturing autologous human progenitor stem cells and applications thereof |
| 12/23/2009 | CN100572380C Berberine ion pair compound, preparing method and drug containing same |
| 12/23/2009 | CN100572378C Improved cinepazide maleate preparation method |
| 12/23/2009 | CN100572360C Isoquinoline compound and its salt preparation method and application |
| 12/23/2009 | CN100571777C Composition containing ADP receptor antagonist and nitrate medicine |
| 12/23/2009 | CN100571739C Compound traditional Chinese medicine for treating cardiovascular diseases and its preparing process |
| 12/23/2009 | CN100571726C Medicinal compositions |
| 12/23/2009 | CN100571719C Production of vermilion injection for treating cardiovascular disease |
| 12/23/2009 | CN100571717C Ilex pubescens extract for treating angitis and its preparation |
| 12/23/2009 | CN100571708C Medicinal composition having cooperative action |
| 12/23/2009 | CN100571703C Sustained-release micro-pellet of trimetazidine and preparation process thereof |
| 12/23/2009 | CN100571697C Drop pills of seabuckthorn fruit flavone |
| 12/23/2009 | CN100571686C Compound drop pills with Chinese medicinal effective part and its preparation method |
| 12/23/2009 | CN100571525C Bamboo charcoal bag health-care tea |
| 12/23/2009 | CA2728156A1 Pyridone compounds |
| 12/23/2009 | CA2727987A1 Renin inhibitors and method of use thereof |
| 12/23/2009 | CA2727465A1 Improved peptide mediators of cholesterol efflux |
| 12/23/2009 | CA2727069A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors |
| 12/23/2009 | CA2727036A1 Triazolopyridine jak inhibitor compounds and methods |
| 12/23/2009 | CA2726844A1 Triazolopyridine jak inhibitor compounds and methods |
| 12/23/2009 | CA2726337A1 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
| 12/23/2009 | CA2725657A1 Novel heteroaryl carboxamide derivatives |
| 12/22/2009 | US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression |
| 12/22/2009 | US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator |
| 12/22/2009 | US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid |
| 12/22/2009 | US7635691 Use of CDP-choline for the prophylactic treatment of cerebral ischemia |
| 12/22/2009 | US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn) |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2462369C Compositions for delivery of drug combinations |
| 12/22/2009 | CA2418059C Method of treating neurodegenerative disorders of the retina and optic nerve head |
| 12/22/2009 | CA2417282C Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/22/2009 | CA2413026C Cold water soluble .beta.-glucan product and process for preparing the same |
| 12/22/2009 | CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
| 12/22/2009 | CA2290744C Cyclic diamine compounds and medicine containing the same |
| 12/22/2009 | CA2214636C Use of leukemia inhibitory factor and endothelin antagonists |
| 12/17/2009 | WO2009152415A2 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade |
| 12/17/2009 | WO2009152160A1 Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension |
| 12/17/2009 | WO2009152111A1 Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium |